LPX-TIGI

N/A

Report date: 2023/12/26 17:50:06
NME

Base Information

Drug NameLPX-TIGI
Drug Alias NameLPX-TIGI
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLAPIX Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLAPIX Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A